Expertise in
27
conditions

Dr. Douglas F. Ciuba

Radiation Oncology Of Columbus PC
Columbus, GA
Expertise in
27
conditions
Specialties:Radiation Oncology
Accepting New Patients
Offers Telehealth
Expertise in
27
conditions
OverviewInsuranceLocationsClinical Research

Overview

Douglas Ciuba is a Radiation Oncologist in Columbus, Georgia. Dr. Ciuba is highly rated in 27 conditions, according to our data. His top areas of expertise are Adenoid Cystic Carcinoma, Lung Cancer, Pleuropulmonary Blastoma, and Familial Prostate Cancer. Dr. Ciuba is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Licenses
Radiology in GA
Hospital Affiliations
St Francis Hospital- Emory Healthcare
Piedmont Columbus Regional Midtown
Emory University Hospital Midtown
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Cigna
  •  Blue Cross Blue Shield
  •  Friday Health
  •  Alliant Health
  •  CareSource
  •  UnitedHealthcare
View 1 More Insurance +

Locations

RADIATION ONCOLOGY OF COLUMBUS PC
1831 5th Ave, Columbus, GA 31904
706-571-1050

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2024
Intervention Type: Radiation
Study Phase: Phase 3
GRECO-1: Phase I/II, Randomized, Placebo-Controlled Study of Stereotactic Body Radiation Therapy (SBRT) and GC4711 for Centrally Located or Large, Node-Negative Non-Small Cell Lung Cancer (NSCLC)
GRECO-1: Phase I/II, Randomized, Placebo-Controlled Study of Stereotactic Body Radiation Therapy (SBRT) and GC4711 for Centrally Located or Large, Node-Negative Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Terminated
Publish Date: April 30, 2024
Intervention Type: Drug
Study Drug: GC4711
Study Phase: Phase 1/Phase 2
ROMAN: Reduction in Oral Mucositis With Avasopasem Manganese (GC4419) - Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer
ROMAN: Reduction in Oral Mucositis With Avasopasem Manganese (GC4419) - Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer
Enrollment Status: Completed
Publish Date: October 24, 2023
Intervention Type: Drug
Study Drug: GC4419
Study Phase: Phase 3
A Phase 2b/3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of Clonidine Mucoadhesive Buccal Tablet to Placebo to Prevent Chemoradiotherapy-induced Severe Oral Mucositis in Patients With Oropharyngeal Cancer
A Phase 2b/3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of Clonidine Mucoadhesive Buccal Tablet to Placebo to Prevent Chemoradiotherapy-induced Severe Oral Mucositis in Patients With Oropharyngeal Cancer
Enrollment Status: Terminated
Publish Date: May 31, 2023
Intervention Type: Drug
Study Drug: Clonidine HCl Mucoadhesive Buccal Tablet
Study Phase: Phase 2/Phase 3
A Phase 2a Open-Label Trial of the Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis in Subjects Receiving Chemoradiotherapy for Lung Cancer
A Phase 2a Open-Label Trial of the Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis in Subjects Receiving Chemoradiotherapy for Lung Cancer
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Drug
Study Drug: GC4419
Study Phase: Phase 2
Open-label, Randomized, Controlled, Phase 3 Safety and Efficacy Study of Trans Sodium Crocetinate With Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
Open-label, Randomized, Controlled, Phase 3 Safety and Efficacy Study of Trans Sodium Crocetinate With Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
Enrollment Status: Terminated
Publish Date: July 22, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
View 5 Less Clinical Trials

1 Total Publications

Updated feasibility and reproducibility results of multi-institutional study of noninvasive breast tumor bed boost.
Updated feasibility and reproducibility results of multi-institutional study of noninvasive breast tumor bed boost.
Journal: Brachytherapy
Published: April 16, 2016
Similar Doctors
Expertise in
23
conditions
Dr. Woodrow W. Mcwilliams
Radiation Oncology
Expertise in
23
conditions
Dr. Woodrow W. Mcwilliams
Radiation Oncology

Radiation Oncology Of Columbus PC

1831 5th Ave, 
Columbus, GA 
706-571-1050
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Woodrow Mcwilliams is a Radiation Oncologist in Columbus, Georgia. Dr. Mcwilliams is highly rated in 23 conditions, according to our data. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Laryngeal Cancer, and Pleuropulmonary Blastoma. Dr. Mcwilliams is currently accepting new patients.

Expertise in
10
conditions
Dr. John F. Cabelka
Radiation Oncology
Expertise in
10
conditions
Dr. John F. Cabelka
Radiation Oncology

The East Alabama Health Care Authority

2000 Pepperell Pkwy, 
Opelika, AL 
 (26.6 mi)
334-749-3411
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Cabelka is a Radiation Oncologist in Opelika, Alabama. Dr. Cabelka is highly rated in 10 conditions, according to our data. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer. Dr. Cabelka is currently accepting new patients.

Expertise in
9
conditions
Dr. Diana A. Santiago
Radiation Oncology
Expertise in
9
conditions
Dr. Diana A. Santiago
Radiation Oncology

Therapeutic Radiation Oncology, PC

745 Poplar Rd, 
Newnan, GA 
 (62.0 mi)
770-254-9600
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Diana Santiago is a Radiation Oncologist in Newnan, Georgia. Dr. Santiago is highly rated in 9 conditions, according to our data. Her top areas of expertise are Laryngeal Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Familial Prostate Cancer. Dr. Santiago is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile